CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.

Banerjee, Sulagna

CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research May 2014 - 2388-99 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1557-3265

10.1158/1078-0432.CCR-13-2947 doi


AC133 Antigen
Animals
Antigens, CD--genetics
Antigens, Surface--metabolism
Antineoplastic Agents--administration & dosage
Apoptosis--drug effects
Cell Line, Tumor
Cell Movement--genetics
Cell Proliferation--drug effects
Cell Survival--drug effects
Cell Transformation, Neoplastic--genetics
Disease Models, Animal
Diterpenes
Epoxy Compounds
Gene Expression
Glycoproteins--genetics
Immunophenotyping
Mice
Mice, Transgenic
NF-kappa B--metabolism
Neoplastic Stem Cells--drug effects
Organophosphates--administration & dosage
Pancreatic Neoplasms--drug therapy
Peptides--genetics
Phenanthrenes--administration & dosage
Phenotype